Alba Grayston Morales: How IL-1 Signaling Drives Injury and Repair in The Ischaemic Brain
Alba Grayston Morales, Postdoctoral Researcher at CIML, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Glia, adding:
”Thrilled to share our latest work from my postdoc at the Brain Inflammation Group, University of Manchester, now out in Glia!
We show that microglial IL-1β is a key amplifier of early post-stroke injury, with the most pronounced benefits of its deletion seen in female mice.
Beyond acute inflammation, microglial IL-1β also shapes post-stroke neurogenesis in a region-specific way.
Together, these findings add a new piece to the puzzle of how IL-1 signaling drives injury and repair in the ischaemic brain, supporting a model in which microglial IL-1α and IL-1β play distinct, non-redundant roles after stroke.”
Title: Specific Deletion of Interleukin-1 Beta in Microglia Improves Acute Outcome and Modulates Neurogenesis After Ischemic Stroke
Authors: Alba Grayston, Margarida Baptista, Kelly Wemyss, Ruby Taylor, Grace Cullen, Syeda S. Jafree, Nadim Luka, Joshua R. Cox, Joanne E. Konkel, David Brough, Stuart M. Allan, Emmanuel Pinteaux
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 13, 2026, 18:25Miguel Gómez Álvarez: Reviewing Inflammation, Transplantation, and Gene Therapy in Hemoglobinopathies
-
Jun 13, 2026, 18:24Ana Pedrero Gil: Why Factor XIII Deficiency Is Often Overlooked During Acute Bleeding
-
Jun 13, 2026, 18:23Tobias Degsell: Building Stronger Bridges Across Disciplines, Countries, and Perspectives at EHA 2026
-
Jun 13, 2026, 18:22Haemoglobinopathies, Innovation, Patient Experience, and Equitable Access at EHA 2026 – TIF
-
Jun 13, 2026, 18:21Thomas Stauch: Discussing the Future of ITP Research and Patient Care
-
Jun 13, 2026, 17:11Kim De Keersmaecker: Advancing Hematology Through Shared Expertise at EHA 2026
-
Jun 13, 2026, 17:03Nour Al-Mozain: The Evolving Role of Apheresis Across Clinical Practice
-
Jun 13, 2026, 16:45Sarah Hendry: A Big Day for Gene Therapy Research at EHA 2026
-
Jun 13, 2026, 16:43Akshat Jain: Bridging Innovation and Access in Hematology at EHGCON 2026